Apparent different thrombotic tendency in patients with factor V Leiden and protein C deficiency due to selection of patients

Blood

Volumn 88, Issue 11, 1996, Pages 4205-4208

  Lensen, R P M ^a   Rosendaal, F R ^a   Koster, T ^a   Allaart, C F ^a   De Ronde, H ^a   Vandenbroucke, J P ^a   Reitsma, P H ^a   Bertina, R M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5; PROTEIN C;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD CLOTTING FACTOR 5 DEFICIENCY; CASE CONTROL STUDY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE PREDISPOSITION; GENE MUTATION; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; ONSET AGE; PATIENT SELECTION; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; THROMBOEMBOLISM; THROMBOPHILIA; VEIN THROMBOSIS;

EID: 0029860101     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.11.4205.4205     Document Type: Article

References (14)

1. Esmon CT: The protein C anticoagulant pathway. Arterioscler Thromb 12:135, 1992
2. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH: Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64 1994
3. Greengard JS, Sun X, Xu X, Fernandez JA, Griffin JH, Evatt B: Activated protein C resistance caused by Arg 506 Gln mutation in factor Va. Lancet 343:1361, 1994
4. 506 of factor V. Lancet 343:1535, 1994
5. Koster T, Rosendaal FR, Ronde H de, Briët E, Vandenbroucke JP, Bertina RM: Venous Thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 342:1503, 1993
6. Koster T, Rosendaal FR, Briët E, van der Meer FJM, Colly LP, Trienekens PH, Poort SR, Vandenbroucke JP: Protein C deficiency in a controlled series of unselected out-patients: An infrequent but clear risk factor for venous thrombosis - Leiden Thrombophilia Study (LETS). Blood 85:2756, 1995
7. Martinelli I, Monzani ML, Faioni EM, Razzari C, Mannucci PM: Clinical features of resistance to activated protein C to other inherited thrombophilic syndromes. Thromb Haemost 73:1123, 1995 (abstr)
8. Engesser L, Brommer EJ, Kluft C, Briët E: Elevated plasminogen activation inhibitor (PAI), a cause of thrombophilia? A study in 203 patients with familial or sporadic venous thrombophilia. Thromb Haemost 62:673, 1989
9. Allaart CF, Poort SR, Rosendaal FR, Reitsma PH, Bertina RM, Briët E: Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect. Lancet 341:134, 1993
10. Majerus PW: Bad blood by mutation. Nature 369:14, 1994
11. Koeleman PC, Reitsma PH, Allaart CF, Bertina RM: Activated protein C resistance as an additional risk factor for thrombosis in protein C deficient families. Blood 84:1031, 1994
12. Vandenbroucke JP, Koster T, Briët E, Reitsma PH, Bertina RM, Rosendaal FR: Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet 344:1453, 1994
13. Gandrille S, Greengard JS, Alhenc Gelas M, Juhan-Vague I, Abgrall JF, Jude B, Griffin JH, Aiach M, the French network on behalf of INSERM: Incidence of activated protein C resistance caused by the ARG 506 GLN mutation in factor V in 113 unrelated symptomatic protein C-deficient patients. Blood 86:219, 1995
14. Zöller B, Berntsdotter A, Garcia de Frutos P, Dahlbäck B: Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S. Blood 85:3518, 1995